Comparative Pharmacology
Head-to-head clinical analysis: AVENTYL versus JANIMINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AVENTYL versus JANIMINE.
AVENTYL vs JANIMINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nortriptyline, the active ingredient, inhibits the reuptake of norepinephrine and serotonin in the central nervous system, potentiating their effects. It also has anticholinergic and antihistaminergic properties.
Imipramine inhibits the reuptake of norepinephrine and serotonin at nerve terminals, potentiating their neurotransmission. It also has anticholinergic and antihistaminergic effects.
Adults: 25 mg orally 3 to 4 times daily, maximum 150 mg/day.
25-50 mg orally 2-4 times daily; maintenance 150 mg/day divided
None Documented
None Documented
Terminal elimination half-life: 19-24 hours; requires 4-6 days to reach steady state.
5-15 hours (terminal elimination half-life); clinical context: requires twice-daily dosing for steady state.
Renal (30% as unchanged drug and metabolites); biliary/fecal (70% as metabolites)
Primarily renal (70-80% as metabolites, 5% unchanged); biliary/fecal (20-30% as metabolites).
Category C
Category C
Tricyclic Antidepressant
Tricyclic Antidepressant